STOCKS TO WATCH
• Hero MotoCorp: To extend the shutdown at its manufacturing facilities across India, global parts Center & R&D facility in Jaipur till May 9. The plant operations to resume on May 10.
• Mahindra & Mahindra: To increase its stake in Meru Travel Solutions to 100%. M&M will acquire 44.14% shares from private equity investors, True North, Bennett Coleman & Co and former Meru cabs CEO, Nilesh Sangoi, for Rs 76.03 crore and 12.66% shares from Neeraj Gupta and Farhat Gupta for Rs 21.63 crore. With this, M&M will enhance its current shareholding in Meru from 43.20% to 100%. Further, Pravin shah, former President at M&M’s automotive division to take over as CEO of Meru and its subsidiaries from May 1.
• HDFC Bank: Has announced a new business structure under Sashidhar Jagdishan as MD & CEO. The bank will reorganise itself into three areas: business verticals, delivery channels and technology/digital. It will increase focus on MSME business and will continue to invest in all its delivery channels.
• DCB Bank: Has acquired equity stake in India INX and India ICC. The bank has invested Rs 5 crore each in the two companies. India INX and India ICC are promoted by BSE and are the leading exchange and clearing corporation in the GIFT City IFSC at Gandhinagar.
• Bank of India: Board has approved raising up to Rs 4,800 crore capital. The bank will raise Rs 3,000 crore by issuance of fresh equity capital in the form of FPO/QIP/Basel Ill Compliant Additional Tier-1 bonds (domestic and foreign currency) and Rs 1,800 crore via Basel III compliant Tier-2 bonds.
• NLC India: Board has approved the proposal for issuance of bonds in the nature of debentures of up to Rs 5,000 crore in tranches.
• MOIL: Has cut manganese ore prices by about 5% across all grades with effect from May 1.
• Rashtriya Chemicals and Fertilizers: Has appointed Crawford Bayley along with its International consortium partner Squire Patton Boggs Singapore LLP as legal advisers for disinvestment of 10% paid-up equity capital, out of the Government of India’s shareholding, through offer for sale.
• Coal India: Production in April up 3.7% year-on-year to 41.9 MT while Offtake rose 38.4% year-on-year to 54.1 MT.
• Titan Company: Has incorporated TCL North America Inc. as its wholly-owned subsidiary in the State of Delaware, the USA for $300,000. TCL North America Inc. will carry on the business of jewellery retailing.
• Ajanta Pharma, Ipca Laboratories, Alembic Pharmaceuticals and Glenmark Pharmaceuticals have subscribed to partnership interest in ABCD Technologies (to be renamed as IndoHealth Services LLP). Ajanta Pharma and Ipca Laboratories will invest Rs 25 crore each for a 4.03% share in ABCD Technologies and Glenmark Pharmaceuticals and Alembic Pharmaceuticals will invest Rs 40 crore each for a 6.45% share.
• Parag Milk Foods: Board has approved the opening of the issue of Foreign Currency Convertible Bonds, aggregating up to $11 million, on April 30. The conversion price of the FCCBs is Rs 145 per share and the floor price is Rs 111.27.
• Nifty Earnings: SBI Life Insurance Company, Kotak Mahindra Bank
• Non-Nifty Earnings: Godrej Properties, L&T Technology Services, IDBI Bank, Tata Chemicals, Apollo Tricoat Tubes, Home First Finance Company India, Mahindra Holidays & Resorts India, Supreme Industries, Varun Beverages
• Hero MotoCorp: To extend the shutdown at its manufacturing facilities across India, global parts Center & R&D facility in Jaipur till May 9. The plant operations to resume on May 10.
• Mahindra & Mahindra: To increase its stake in Meru Travel Solutions to 100%. M&M will acquire 44.14% shares from private equity investors, True North, Bennett Coleman & Co and former Meru cabs CEO, Nilesh Sangoi, for Rs 76.03 crore and 12.66% shares from Neeraj Gupta and Farhat Gupta for Rs 21.63 crore. With this, M&M will enhance its current shareholding in Meru from 43.20% to 100%. Further, Pravin shah, former President at M&M’s automotive division to take over as CEO of Meru and its subsidiaries from May 1.
• HDFC Bank: Has announced a new business structure under Sashidhar Jagdishan as MD & CEO. The bank will reorganise itself into three areas: business verticals, delivery channels and technology/digital. It will increase focus on MSME business and will continue to invest in all its delivery channels.
• DCB Bank: Has acquired equity stake in India INX and India ICC. The bank has invested Rs 5 crore each in the two companies. India INX and India ICC are promoted by BSE and are the leading exchange and clearing corporation in the GIFT City IFSC at Gandhinagar.
• Bank of India: Board has approved raising up to Rs 4,800 crore capital. The bank will raise Rs 3,000 crore by issuance of fresh equity capital in the form of FPO/QIP/Basel Ill Compliant Additional Tier-1 bonds (domestic and foreign currency) and Rs 1,800 crore via Basel III compliant Tier-2 bonds.
• NLC India: Board has approved the proposal for issuance of bonds in the nature of debentures of up to Rs 5,000 crore in tranches.
• MOIL: Has cut manganese ore prices by about 5% across all grades with effect from May 1.
• Rashtriya Chemicals and Fertilizers: Has appointed Crawford Bayley along with its International consortium partner Squire Patton Boggs Singapore LLP as legal advisers for disinvestment of 10% paid-up equity capital, out of the Government of India’s shareholding, through offer for sale.
• Coal India: Production in April up 3.7% year-on-year to 41.9 MT while Offtake rose 38.4% year-on-year to 54.1 MT.
• Titan Company: Has incorporated TCL North America Inc. as its wholly-owned subsidiary in the State of Delaware, the USA for $300,000. TCL North America Inc. will carry on the business of jewellery retailing.
• Ajanta Pharma, Ipca Laboratories, Alembic Pharmaceuticals and Glenmark Pharmaceuticals have subscribed to partnership interest in ABCD Technologies (to be renamed as IndoHealth Services LLP). Ajanta Pharma and Ipca Laboratories will invest Rs 25 crore each for a 4.03% share in ABCD Technologies and Glenmark Pharmaceuticals and Alembic Pharmaceuticals will invest Rs 40 crore each for a 6.45% share.
• Parag Milk Foods: Board has approved the opening of the issue of Foreign Currency Convertible Bonds, aggregating up to $11 million, on April 30. The conversion price of the FCCBs is Rs 145 per share and the floor price is Rs 111.27.
• Nifty Earnings: SBI Life Insurance Company, Kotak Mahindra Bank
• Non-Nifty Earnings: Godrej Properties, L&T Technology Services, IDBI Bank, Tata Chemicals, Apollo Tricoat Tubes, Home First Finance Company India, Mahindra Holidays & Resorts India, Supreme Industries, Varun Beverages
P&G HYGIENE AND HEALTH CARE:
Q4 SL NET PROFIT 983.3M RUPEES VS 911M (YOY); EST 1.5B | 2.51B (QOQ)
Q4 REVENUE 7.6B RUPEES VS 6.56B (YOY)
CO DECLARED A SPECIAL INTERIM DIVIDEND OF 150 RUPEES PER SHARE
Q4 SL NET PROFIT 983.3M RUPEES VS 911M (YOY); EST 1.5B | 2.51B (QOQ)
Q4 REVENUE 7.6B RUPEES VS 6.56B (YOY)
CO DECLARED A SPECIAL INTERIM DIVIDEND OF 150 RUPEES PER SHARE
Prince Pipes and Fittings Ltd board to consider Q4, FY21 results on May 12, 2021
CyberTech Systems and Software Ltd Board to consider Dividend on May 13, 2021
Manappuram Finance Ltd board to announce Q4, FY21 results on May 18, 2021
ICRA Analytics Limited recommends dividend of Rs. 13
Alembic Pharmaceuticals Limited board recommends dividend of Rs. 14
Skipper Limited board recommends dividend of Rs. 0.10
Srikalahasthi Pipes Limited Board recommends Dividend of Rs. 6
ADANI PORT Q4 : Net Profit Up 285 % to Rs 1287 cr (YOY)
Revenue Up 23 % to Rs 3607 cr
Recommends Rs 5 as Final Dividend
RBL BANK:
CO EXEC SAYS FOCUS GOING FORWARD WILL BE TO SCALE UP IN CARDS AND MICROFINANC Q4 : Net Profit Up 285 % to Rs 1287 cr (YOY)
Revenue Up 23 % to Rs 3607 cr
Recommends Rs 5 as Final Dividend
RBL BANK:
CO EXEC SAYS ABOUT 80% OF OUR SLIPPAGES IN FY21 WERE FROM THE RETAIL SEGMENT
SAYS EXPECT NIMS TO NORMALIZE TO 4.75% PLUS LEVELS IN FY22
RBL BANK:
CO EXEC SAYS FOCUS GOING FORWARD WILL BE TO SCALE UP IN CARDS AND MICROFINANCE BUSINESS
CO EXEC SAYS WE WILL SEE WHOLESALE BUSINESS GROW IN HIGH SINGLE DIGITS IN FY22
CyberTech Systems and Software Ltd Board to consider Dividend on May 13, 2021
Manappuram Finance Ltd board to announce Q4, FY21 results on May 18, 2021
ICRA Analytics Limited recommends dividend of Rs. 13
Alembic Pharmaceuticals Limited board recommends dividend of Rs. 14
Skipper Limited board recommends dividend of Rs. 0.10
Srikalahasthi Pipes Limited Board recommends Dividend of Rs. 6
ADANI PORT Q4 : Net Profit Up 285 % to Rs 1287 cr (YOY)
Revenue Up 23 % to Rs 3607 cr
Recommends Rs 5 as Final Dividend
RBL BANK:
CO EXEC SAYS FOCUS GOING FORWARD WILL BE TO SCALE UP IN CARDS AND MICROFINANC Q4 : Net Profit Up 285 % to Rs 1287 cr (YOY)
Revenue Up 23 % to Rs 3607 cr
Recommends Rs 5 as Final Dividend
RBL BANK:
CO EXEC SAYS ABOUT 80% OF OUR SLIPPAGES IN FY21 WERE FROM THE RETAIL SEGMENT
SAYS EXPECT NIMS TO NORMALIZE TO 4.75% PLUS LEVELS IN FY22
RBL BANK:
CO EXEC SAYS FOCUS GOING FORWARD WILL BE TO SCALE UP IN CARDS AND MICROFINANCE BUSINESS
CO EXEC SAYS WE WILL SEE WHOLESALE BUSINESS GROW IN HIGH SINGLE DIGITS IN FY22
*Important News:* RBI Decision to Buy Rs 35K Crore Govt Securities Might Make Home Loans Cheaper - Watch out the Home finance Stocks..
MAITHAN ALLOY Q4 : Net Profit Up 33 % to Rs 85 cr (YOY)
Revenue Up 23 % to Rs 499 cr
Board Recommends Rs 6 as final Dividend
GILLETTE INDIA Q4 : Net Profit Up 101 % to Rs 105 cr (YOY)
Revenue Up 32 % to Rs 536 cr
Announces Rs 50 as Special Dividend.. Record date may 14
JM FINANCIAL Q4 : Net Profit up 35 % to Rs 176 cr (YOY)
Revenue Down 1 % to Rs 825 cr
Recommends Rs 0.50 as final Dividend
Revenue Up 23 % to Rs 499 cr
Board Recommends Rs 6 as final Dividend
GILLETTE INDIA Q4 : Net Profit Up 101 % to Rs 105 cr (YOY)
Revenue Up 32 % to Rs 536 cr
Announces Rs 50 as Special Dividend.. Record date may 14
JM FINANCIAL Q4 : Net Profit up 35 % to Rs 176 cr (YOY)
Revenue Down 1 % to Rs 825 cr
Recommends Rs 0.50 as final Dividend
Stocks To Watch
• IDBI Bank: Cabinet Committee on Economic Affairs has approved the strategic divestment of IDBI Bank, along with a transfer of management control. The extent of respective shareholding to be divested by government and Life Insurance Corporation to be decided at the time of structuring of transaction in consultation with RBI.
• Tata Motors: Competition Commission of India has ordered a detailed probe against Tata Motors for alleged abuse of dominant position with respect to dealership agreements. The order has come on two complaints filed against Tata Motors, Tata Capital Financial Services and Tata Motors Finance. A clause in the dealership agreement allows Tata Motors to restrict, confine the territory of its dealers. Such a clause can create barriers to new entrants in the restricted market and can result in foreclosing of competition by hindering entry into the market, the competition regulator said.
• Cipla: Roche has received emergency use authorisation in India for its investigational antibody cocktail (Casirivimab and Imdevimab) used in the treatment of Covid-19. The EUA will now enable Roche to import the globally manufactured product batches to India which will be marketed and distributed in India through a strategic partnership with Cipla.
• Wipro: Has partnered with Transcell Oncologics to transform vaccine safety assessment using augmented intelligence. Transcell’s stem cell technology with the augmented intelligence capabilities of Wipro HOLMES® to improve the safety of global vaccine immunisation programs. Also, by applying AI to the vaccine development process, our solution can predict adverse neurovirulent impacts resulting from vaccinations, the company said.
• Godrej Industries: Board has approved the Information memorandum for issuance of up to 7,500 listed, unsecured NCDs of the face value of Rs 10 lakh each, aggregating to Rs 750 crore on a private placement basis.
• Maruti Suzuki: Total production in April stood at 1.59 lakh units. Total passenger vehicle production stood at 1.57 lakh units.
• Force Motors: The company's total production in April stood at 1,042 units. It reported domestic sales of 1,094 units and exports of 187 units.
• Indian Bank: Has declared Saravan Stores (Gold Palace) bad loan account as fraud and reported it to the RBI.
• Bank of India: Has approved allotment of up to 42.11 crore shares at Rs 71.23 per share aggregating up to Rs 3,000 crore on a preferential basis to the Government of India.
• Quess Corp: Has declared an interim dividend of Rs 7 per share for FY21. The record date for the same is May 13.
• Nifty Earnings: Tata Consumer Products, Hero MotoCorp
• Non-Nifty Earnings: Adani Power, Adani Transmission, Apcotex Industries, Bombay Burmah Trading Corp, Blue Star, Caplin Point Laboratories, Century Textiles & Industries, Coforge, CreditAccess Grameen, Foseco India, Hikal, ICRA, IIFL Finance, Procter & Gamble Health, Praj Industries, Raymond, Solara Active Pharma Sciences, Sundram Fasteners
• IDBI Bank: Cabinet Committee on Economic Affairs has approved the strategic divestment of IDBI Bank, along with a transfer of management control. The extent of respective shareholding to be divested by government and Life Insurance Corporation to be decided at the time of structuring of transaction in consultation with RBI.
• Tata Motors: Competition Commission of India has ordered a detailed probe against Tata Motors for alleged abuse of dominant position with respect to dealership agreements. The order has come on two complaints filed against Tata Motors, Tata Capital Financial Services and Tata Motors Finance. A clause in the dealership agreement allows Tata Motors to restrict, confine the territory of its dealers. Such a clause can create barriers to new entrants in the restricted market and can result in foreclosing of competition by hindering entry into the market, the competition regulator said.
• Cipla: Roche has received emergency use authorisation in India for its investigational antibody cocktail (Casirivimab and Imdevimab) used in the treatment of Covid-19. The EUA will now enable Roche to import the globally manufactured product batches to India which will be marketed and distributed in India through a strategic partnership with Cipla.
• Wipro: Has partnered with Transcell Oncologics to transform vaccine safety assessment using augmented intelligence. Transcell’s stem cell technology with the augmented intelligence capabilities of Wipro HOLMES® to improve the safety of global vaccine immunisation programs. Also, by applying AI to the vaccine development process, our solution can predict adverse neurovirulent impacts resulting from vaccinations, the company said.
• Godrej Industries: Board has approved the Information memorandum for issuance of up to 7,500 listed, unsecured NCDs of the face value of Rs 10 lakh each, aggregating to Rs 750 crore on a private placement basis.
• Maruti Suzuki: Total production in April stood at 1.59 lakh units. Total passenger vehicle production stood at 1.57 lakh units.
• Force Motors: The company's total production in April stood at 1,042 units. It reported domestic sales of 1,094 units and exports of 187 units.
• Indian Bank: Has declared Saravan Stores (Gold Palace) bad loan account as fraud and reported it to the RBI.
• Bank of India: Has approved allotment of up to 42.11 crore shares at Rs 71.23 per share aggregating up to Rs 3,000 crore on a preferential basis to the Government of India.
• Quess Corp: Has declared an interim dividend of Rs 7 per share for FY21. The record date for the same is May 13.
• Nifty Earnings: Tata Consumer Products, Hero MotoCorp
• Non-Nifty Earnings: Adani Power, Adani Transmission, Apcotex Industries, Bombay Burmah Trading Corp, Blue Star, Caplin Point Laboratories, Century Textiles & Industries, Coforge, CreditAccess Grameen, Foseco India, Hikal, ICRA, IIFL Finance, Procter & Gamble Health, Praj Industries, Raymond, Solara Active Pharma Sciences, Sundram Fasteners
Bajaj Finserv launches 'SavdhanRahein. Safe Rahein', a Public Awareness Campaign on Financial Fraud Risks
Domestic pharma growth at 51.5% for April as per AIOCD.
GODREJ AGROVET:
Q4 CONS NET PROFIT 565.9M RUPEES VS 746M (YOY); EST 530M | 616M (QOQ)
Q4 REVENUE 14.62B RUPEES VS 16.28B (YOY)
CO RECOMMENDED FINAL DIVIDEND OF 8 RUPEES PER SHARE
Domestic pharma growth at 51.5% for April as per AIOCD.
GODREJ AGROVET:
Q4 CONS NET PROFIT 565.9M RUPEES VS 746M (YOY); EST 530M | 616M (QOQ)
Q4 REVENUE 14.62B RUPEES VS 16.28B (YOY)
CO RECOMMENDED FINAL DIVIDEND OF 8 RUPEES PER SHARE